You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-22. Secondary drugs cited by clients entering treatment, 2011 or most recent year available
Part (i) Outpatient units
| Secondary drug | Number of citations by all clients | % |
|---|---|---|
| Volatile Inhalants | 675 | 0.22 |
| Hallucinogens | 2676 | 0.88 |
| Stimulants | 15881 | 5.22 |
| Hypnotics and Sedatives | 19502 | 6.41 |
| Opioids | 21679 | 7.13 |
| Other Substances | 30080 | 9.89 |
| Cocaine | 54404 | 17.88 |
| Alcohol | 73521 | 24.16 |
| Cannabis | 85839 | 28.21 |
| Total number of citations | 304257 | 100 |
Notes
For information on the countries supplying data and the number of treatment clients in each country see Table TDI-7.
See also 'General notes for interpreting data’ on the Explanatory notes and help page.
Source:
Reitox national reports 2012 — Table TDI.